EUA
Omnia SARS-CoV-2 Antigen Test
FDA Emergency Use Authorization · Qorvo Biotechnologies, LLC. · May 3, 2023
Key facts
| Product | Omnia SARS-CoV-2 Antigen Test |
|---|---|
| Company | Qorvo Biotechnologies, LLC. |
| Product type | Bulk Acoustic Wave (BAW) Biosensor, Instrument Read, Serial Screening, Single Target |
| Date | May 3, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: